Abstract
Angioinvasion is the rate limiting step in metastatic tumor progression. Among the very few proteins ultimately necessary for angioinvasion is urokinase plasminogen activator receptor (uPAR). Hypoxia-Inducible-Factor-1 (HIF-1) is found to be activated during progression of human pancreatic cancer, a tumor which grows in a microenvironment of low oxygen. However, it is not know whether a relationship between HIF-1 and uPAR exists. Transcriptional control of uPAR expression by HIF-1 has never been reported. AimThe aims of this study were to analyze whether HIF-1 transcriptionally regulates uPAR and to analyze the role of hypoxia in angioinvasion and metastasis formation. MethodsFour human pancreatic cancer cell lines Capan-2 (C2), HPAF-2 (HP2), MIA PaCa-2 (MP2) and PANC-1 were used. Northern blot analysis was used to quantify mRNA expression and a nuclear run of assay to determine newly transcribed mRNA. DNA binding was studied with gelshift assays. PCR generated deletion mutants of the uPAR promotor were used in Luciferase assays to determine reporter gene activity. To study angioinvasion of PaCa cell lines Matrigel invasion assays and fertilized chicken eggs were used for chorioallantoic membrane (CAM) assays. ResultsuPAR but not uPA mRNA expression is upregulated by low oxygen levels. Cell lines not expressing uPAR under normoxic (C2) conditions reconstitute uPAR production under hypoxia. Actual hypoxia induced uPAR mRNA transcription. Transcriptional activation of HIF-1 by binding to the uPAR promotor was detectable within the first hour after onset of hypoxia. Promotor deletion mutants containing the putative HIF-1 binding site showed a significant increase in reporter gene activity. In vitro invasion assays revealed that hypoxia increased the relative number of invading tumor cells. Moreover, hypoxia was a strong uPAR dependent stimulus in angioinvasion assays in vivo in all cell lines tested. ConclusionIn this study we present for the first time, that uPAR is under transcriptional control of HIF-1 and further show that hypoxic upregulation of uPAR is caused by an actual increase in transcription of uPAR mRNA synthesis. We further show that this mechanism also increased the potential of metastatic growth of pancreatic cancer, both in vitro and in vivo in an uPAR dependent manner.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Parker SL, Davis KJ, Wingo PA, Gries LA, Heath CW Jr (1998) Cancer statistics by race and ethnicity. Ca: a Cancer Journal for Clinicians 48: 31–48
Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler MW (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358: 1576–1585
Kim J, Yu W, Kovalski K, Ossowski L (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353–362
Buchler P, Reber HA, Buchler MW, Friess H, Hines OJ (2002) VEGF-RII Influences the Prognosis of Pancreatic Cancer. Ann Surg 236: 738–749
Friess H, Yamanaka Y, Buchler M, Berger HG, Kobrin MS, Baldwin RL, Korc M (1993) Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 53: 2704–2707
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Büchler, P., Friess, H., Müller, M.W., Reber, H.A., Hines, O.J., Büchler, M.W. (2003). HIF-1 steuert die Angioinvasion und Metastasierung durch Regulation der uPAR — Genexpression beim Pankreaskarzinom. In: Menger, M.D., Haas, N.P., Neugebauer, E., Bauer, H. (eds) Chirurgisches Forum 2003 für experimentelle und klinische Forschung. Deutsche Gesellschaft für Chirurgie, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19024-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-19024-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00659-6
Online ISBN: 978-3-642-19024-7
eBook Packages: Springer Book Archive